HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AHPA Hoodia Committee To Promote “Responsible Commerce”

This article was originally published in The Tan Sheet

Executive Summary

A newly formed committee will "promote and protect responsible commerce of products" containing Hoodia gordonii, the American Herbal Products Association announced Nov. 22

You may also be interested in...

Hoodia Lawsuit Could Plant Seeds Of Concern Over Ingredient Testing

A suit recently filed by a dietary supplement manufacturer against an ingredient supplier could raise far-reaching questions throughout the hoodia market about product authenticity and compliance with good manufacturing practices

Supplement Industry Could Face Competition From Hoodia Gordonii Foods

Phytopharm could have a line of food products containing Hoodia gordonii on the market by 2008

TrimSpa Ephedra Free Ingredient Claims Targeted In Class Action Lawsuits

Two class action lawsuits filed in state courts against supplement manufacturer Nutramerica allege that the firm's TrimSpa Completely Ephedra Free Formula X32 ("TrimSpa EF") diet product line does not contain the appetite suppressant it claims





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts